duction level has not even reached half the of 1991 and yet against such a poor background hemofarm recorded production growth 8 percent foundation is strong over last ten year period s drug increased by 668 we have upgraded our manufac turing facilities expanded capacities main stumbling block country economy been lack investment in state art tech nologies this precisely where worked i am proud to be leading winning successful team that are able demon strate very con scientious dedicated common goal further devel opment group environment especially fact path success was uninterrupted spite all negative trends never accepted mediocrity sought what for many years model others coun try decline industrial lower 3 national pro intensively during two
